BIRC5 and neoplasm: For instance, targeting dimerization of survivin, which was known as a homodimeric member of the inhibitor of apoptosis protein (IAP) family, with inhibitors induces its proteasome‐dependent degradation and effectively inhibits xenograft tumour growth.52, 53